nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.01	0.01	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.00952	0.00952	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00951	0.00951	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—FSHR—polycystic ovary syndrome	0.0089	0.0089	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00885	0.00885	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00885	0.00885	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00841	0.00841	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.008	0.008	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00782	0.00782	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00752	0.00752	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.00744	0.00744	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.00724	0.00724	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00715	0.00715	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—GHRL—polycystic ovary syndrome	0.00709	0.00709	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—ACE—polycystic ovary syndrome	0.00686	0.00686	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—NPB—polycystic ovary syndrome	0.00682	0.00682	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00678	0.00678	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00665	0.00665	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—TCF7L2—polycystic ovary syndrome	0.00659	0.00659	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00632	0.00632	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—DLG4—polycystic ovary syndrome	0.00599	0.00599	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00576	0.00576	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—PTGER3—polycystic ovary syndrome	0.00569	0.00569	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—ADRA1A—polycystic ovary syndrome	0.00548	0.00548	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00548	0.00548	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00542	0.00542	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00528	0.00528	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00528	0.00528	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.00528	0.00528	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—DLG4—polycystic ovary syndrome	0.0051	0.0051	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00505	0.00505	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00494	0.00494	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00491	0.00491	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—DLG4—polycystic ovary syndrome	0.00484	0.00484	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00479	0.00479	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—CGB5—polycystic ovary syndrome	0.00477	0.00477	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00466	0.00466	CbGpPWpGaD
Doxacurium chloride—CHRM2—Regulation of Actin Cytoskeleton—FGF18—polycystic ovary syndrome	0.00458	0.00458	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.00452	0.00452	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.00452	0.00452	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—MANEA—polycystic ovary syndrome	0.00436	0.00436	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—LEP—polycystic ovary syndrome	0.00426	0.00426	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00423	0.00423	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—ADRB2—polycystic ovary syndrome	0.00423	0.00423	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00413	0.00413	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00411	0.00411	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.004	0.004	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00399	0.00399	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00399	0.00399	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00394	0.00394	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00386	0.00386	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.0038	0.0038	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—POMC—polycystic ovary syndrome	0.00366	0.00366	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—INS—polycystic ovary syndrome	0.00364	0.00364	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—CPB2—polycystic ovary syndrome	0.00361	0.00361	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ADAMTS7—polycystic ovary syndrome	0.00361	0.00361	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00353	0.00353	CbGpPWpGaD
Doxacurium chloride—BCHE—Peptide hormone metabolism—IGF1—polycystic ovary syndrome	0.00352	0.00352	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00349	0.00349	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00344	0.00344	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00344	0.00344	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.0034	0.0034	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.00334	0.00334	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00331	0.00331	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—MTNR1B—polycystic ovary syndrome	0.00324	0.00324	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00322	0.00322	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.00317	0.00317	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00313	0.00313	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00312	0.00312	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00304	0.00304	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00303	0.00303	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00302	0.00302	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00302	0.00302	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00301	0.00301	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00291	0.00291	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00288	0.00288	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.00285	0.00285	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00282	0.00282	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00278	0.00278	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—INHBB—polycystic ovary syndrome	0.00274	0.00274	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—DLG4—polycystic ovary syndrome	0.00267	0.00267	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.00264	0.00264	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00257	0.00257	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00257	0.00257	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00252	0.00252	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—NMNAT3—polycystic ovary syndrome	0.00246	0.00246	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—RPL37A—polycystic ovary syndrome	0.00246	0.00246	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.00234	0.00234	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00233	0.00233	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00231	0.00231	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00229	0.00229	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—LPCAT2—polycystic ovary syndrome	0.00225	0.00225	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—SUOX—polycystic ovary syndrome	0.00225	0.00225	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00225	0.00225	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00222	0.00222	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.00222	0.00222	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00219	0.00219	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00214	0.00214	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00212	0.00212	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00211	0.00211	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ISYNA1—polycystic ovary syndrome	0.00209	0.00209	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00207	0.00207	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00207	0.00207	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00206	0.00206	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00204	0.00204	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—LHB—polycystic ovary syndrome	0.00203	0.00203	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00196	0.00196	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00195	0.00195	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00195	0.00195	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00192	0.00192	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00191	0.00191	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.0019	0.0019	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00184	0.00184	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00184	0.00184	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00182	0.00182	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—IGFBP1—polycystic ovary syndrome	0.00181	0.00181	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00181	0.00181	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—AKR1C2—polycystic ovary syndrome	0.00178	0.00178	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—TEAD2—polycystic ovary syndrome	0.00178	0.00178	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00177	0.00177	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00177	0.00177	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00177	0.00177	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00172	0.00172	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.00171	0.00171	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00168	0.00168	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00165	0.00165	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00161	0.00161	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00157	0.00157	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00156	0.00156	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00156	0.00156	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.0015	0.0015	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.00149	0.00149	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00145	0.00145	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00143	0.00143	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00142	0.00142	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00142	0.00142	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.00141	0.00141	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—STAR—polycystic ovary syndrome	0.00135	0.00135	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.00134	0.00134	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00133	0.00133	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.0013	0.0013	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.0013	0.0013	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00129	0.00129	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00125	0.00125	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00125	0.00125	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00124	0.00124	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00121	0.00121	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—HMMR—polycystic ovary syndrome	0.0012	0.0012	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.0012	0.0012	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00118	0.00118	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00116	0.00116	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.00115	0.00115	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00114	0.00114	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00113	0.00113	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00113	0.00113	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00113	0.00113	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00111	0.00111	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00111	0.00111	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.0011	0.0011	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.00108	0.00108	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00107	0.00107	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00105	0.00105	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—LHB—polycystic ovary syndrome	0.00104	0.00104	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00104	0.00104	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00104	0.00104	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.00102	0.00102	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00101	0.00101	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.000989	0.000989	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000983	0.000983	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000977	0.000977	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000948	0.000948	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000922	0.000922	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	0.00091	0.00091	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000899	0.000899	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—RRM2—polycystic ovary syndrome	0.000881	0.000881	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—YAP1—polycystic ovary syndrome	0.000849	0.000849	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000839	0.000839	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000818	0.000818	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	0.000816	0.000816	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000811	0.000811	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	0.000806	0.000806	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000805	0.000805	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.0008	0.0008	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000764	0.000764	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000761	0.000761	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.000749	0.000749	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000748	0.000748	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000745	0.000745	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000743	0.000743	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000719	0.000719	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000699	0.000699	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.000691	0.000691	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.000687	0.000687	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000681	0.000681	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000677	0.000677	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000673	0.000673	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000665	0.000665	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000665	0.000665	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00065	0.00065	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—TH—polycystic ovary syndrome	0.000648	0.000648	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.000631	0.000631	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000629	0.000629	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000628	0.000628	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000623	0.000623	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000615	0.000615	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000594	0.000594	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.000593	0.000593	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000584	0.000584	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000579	0.000579	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00057	0.00057	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000541	0.000541	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000533	0.000533	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—GNAS—polycystic ovary syndrome	0.000529	0.000529	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.00051	0.00051	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000504	0.000504	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000485	0.000485	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000478	0.000478	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000477	0.000477	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000472	0.000472	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000446	0.000446	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000439	0.000439	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000439	0.000439	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000423	0.000423	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000419	0.000419	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000408	0.000408	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000407	0.000407	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000386	0.000386	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000384	0.000384	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000383	0.000383	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000369	0.000369	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000363	0.000363	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—PPARG—polycystic ovary syndrome	0.000361	0.000361	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—POMC—polycystic ovary syndrome	0.000356	0.000356	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—INS—polycystic ovary syndrome	0.000354	0.000354	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000337	0.000337	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000321	0.000321	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000315	0.000315	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00027	0.00027	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000264	0.000264	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000236	0.000236	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000227	0.000227	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	0.000226	0.000226	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000218	0.000218	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000218	0.000218	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000207	0.000207	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000167	0.000167	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000143	0.000143	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	9.86e-05	9.86e-05	CbGpPWpGaD
